Operating Expenses Changement Date
Abbott USD 8.45B 21M 2023-12
AngioDynamics USD 43.65M 68.26M 2023-06
AtriCure USD 115.21M 8.83M 2023-12
Baxter International USD 3.59B 173M 2023-12
Becton, Dickinson and Co. USD 4.27B 471M 2023-12
Boston Scientific USD 3.14B 307M 2023-12
Edwards Lifesciences USD 1.13B 71.5M 2023-12
Integra LifeSciences USD 361.11M 5.16M 2023-12
J&J USD 16.57B 435M 2023-12
Pfizer USD 20.8B 4.62B 2023-12
ResMed USD 887.71M 74.38M 2023-12
Stryker USD 4.56B 580M 2023-12
Surmodics USD 30.42M 651K 2023-09
Tandem Diabetes Care USD 231.86M 14.69M 2023-12
Teleflex USD 691.44M 110.36M 2023-12
Terumo JPY 191.77B 6.16B 2023-09
Trinity Biotech USD 28.75M 10M 2023-06



Artivion Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.